Trade MNOV stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Medicinova Inc (MNOV) is trading at US$2.90, down 12.12% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$68.42M. Over the past 52 weeks, MNOV has traded between US$1.17 and US$3.90. On Syfe you can trade MNOV with $0 commission and add it to your watchlist.
| Previous close | US$3.30 |
|---|---|
| Market cap | US$68.42M |
| 52-week range | US$1.17 – US$3.90 |
| Volume | 2.47M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Medicinova Inc
MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
Year: 2006
MediciNova Granted US Patent Notice of Allowance for Ibudilast Combination to Treat Brain Cancer
Jun 8, 12:34 PM · MT Newswires
Medicinova Inc (MNOV) stock is trading at US$2.90, -12.12% from the previous close of US$3.30.
The market cap for Medicinova Inc (MNOV) stock is approximately US$68.42M.
The 52-week high for Medicinova Inc (MNOV) stock is US$3.90.
The 52-week low for Medicinova Inc (MNOV) stock is US$1.17.
Medicinova Inc (MNOV) does not currently pay a dividend.
Stay on top of MNOV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
